Results 141 to 150 of about 10,318 (317)

Practical recommendations for treating patients with chronic kidney disease in Australia: a multidisciplinary approach

Internal Medicine Journal, EarlyView.
Abstract Background Chronic kidney disease (CKD) is a significant public health challenge in Australia, affecting ~10% of the adult population and contributing to substantial morbidity and mortality. Diabetes, hypertension, cardiovascular disease and CKD frequently co‐exist; therefore, a multidisciplinary approach is necessary to manage these ...
M. P. Schlaich, W. P. Abhayaratna, R. Audehm, E. I. Ekinci, R. J. MacIsaac, A. J. Nelson, A. Sharma, C. Pollock   +7 more
wiley   +1 more source

The association between glucagon-like peptide-1 receptor agonist and rheumatoid arthritis: a population-based case–control study

Therapeutic Advances in Musculoskeletal Disease
Background: Obesity has been proposed as a risk factor for the development of rheumatoid arthritis (RA). Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are increasingly prescribed for weight reduction and glycemic control and have been shown to ...
Ariel Israel, Fadi Hassan, Eugene Merzon, Jalal Kurtam, Jamal Awad, Mai Assalia, Ilan Green, Shlomo Vinker, Mohammad E. Naffaa   +8 more
doaj   +1 more source

Comparative efficacy and safety of three fixed‐ratio combination products in type 2 diabetes: A network meta‐analysis

Journal of Diabetes Investigation, EarlyView.
Abstract Objective To systematically evaluate and compare the efficacy and safety of three fixed‐ratio combination products—insulin degludec/liraglutide (IDegLira), insulin glargine/lixisenatide (iGlarLixi), and insulin degludec/insulin aspart (IDegAsp)—in patients with type 2 diabetes.
Xiaomei Wang, Jiali Qin, Yang Liu, Xianying Wang   +3 more
wiley   +1 more source

THE POTENTIAL OF GLP-1 IN THE TREATMENT OF AUTOIMMUNE DISEASES: A REVIEW OF MECHANISMS AND CLINICAL DATA [PDF]

Introduction: Autoimmune diseases are a heterogeneous group of disorders characterized by dysregulated immune responses against self-antigens, leading to chronic inflammation and progressive organ damage.
Agata Andrzejczyk, Aleksandra Tomaszewska, Angelika Lewandowska, Gabriela Szpila, Joanna Gadzinowska, Krzysztof Feret, Maciej Kokoszka, Małgorzata Stopyra, Michalina Chodór, Natalia Nafalska   +9 more
core   +2 more sources

The Effect of SGLT-2 inhibitors and GLP-1RA on Major Cardiovascular Conditions: A Meta-Analysis [PDF]

, 2022
Arjun V. Jogimahanti, Kevin A. Honan, Talha Ahmed, Luis León‐Novelo, Tarif Khair   +4 more
openalex   +1 more source

Interpretable machine learning models based on CMR radiomics for predicting left ventricular diastolic dysfunction in patients with metabolic‐associated steatotic liver disease and type 2 diabetes mellitus

Journal of Diabetes Investigation, EarlyView.
We developed an interpretable machine learning (ML) model combining cardiac magnetic resonance (CMR) radiomics and clinical data to assess left ventricular diastolic dysfunction (LVDD) risk in metabolic‐associated steatotic liver disease (MASLD)/type 2 diabetes mellitus (T2DM) patients, enabling proactive treatment.
Jinying Xia, Shaoyi Leng, Bin Xu, Guang Jin, Jianhui Li, Mingchen Zhang, Danzhen Yao, Ruiting Shen, Qifeng Hua   +8 more
wiley   +1 more source

SGLT2 inhibitors and GLP-1 receptor agonists: impact on mortality in diabetic patients with cardiovascular disease

Cardiovascular Diabetology
Background Sodium-glucose cotransporter 2 inhibitors (SGLT2-I) and glucagon-like peptide-1 receptor agonists (GLP-1RA) have been shown to reduce cardiovascular risk and mortality in patients with type 2 diabetes mellitus (T2D), yet remain underutilized ...
Ziad Arow, Tzipi Hornik-Lurie, Ranin Hilu, Ela Giladi, Yoav Arnson, Hana Vaknin-Assa, Abid Assali, David Pereg, For the CARDIAB research group   +8 more
doaj   +1 more source

The Role of GLP-1 Receptor Agonists in Eating Disorders: Appetite Regulation and Neurobiological Mechanisms

Neurologijos seminarai
Valgymo sutrikimai, tokie kaip nervinė anoreksija, nervinė bulimija ir persivalgymo sutrikimas, dažnai siejami su neurobiologinėmis disfunkcijomis, įskaitant dopamino ir atlygio sistemų pokyčius.
Julija Blažytė, Robertas Strumila
doaj   +1 more source

Relative contributions of basal vs postprandial hyperglycaemia to overall glycaemic control in newly diagnosed Chinese adults with type 2 diabetes before and after 3 months' intensive glucose‐lowering therapy

Journal of Diabetes Investigation, EarlyView.
In newly‐diagnosed Chinese with T2D, Contribution of basal hyperglycaemia to hyperglycaemic exposure decreased substantially and the relative importance of postprandial hyperglycaemia increased markedly after 3 months glucose‐lowering therapy. Therapy should be re‐evaluated after initial treatment, and that a greater focus on limiting postprandial ...
Yixuan Sun, Yong Luo, Cong Xie, Karen L. Jones, Michael Horowitz, Christopher K. Rayner, Jianhua Ma, Tongzhi Wu   +7 more
wiley   +1 more source

Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by GLP‐1RA treatment: A subgroup analysis from the FIDELIO‐DKD trial [PDF]

, 2021
Peter Rossing, Rajiv Agarwal, Stefan D. Anker, Gerasimos Filippatos, Bertram Pitt, Luís M. Ruilope, Aslam Amod, Michel Marre, Amer Joseph, Andrea Lage, Charlie Scott, George L. Bakris, the FIDELIO‐DKD Investigators   +12 more
openalex   +1 more source